Endocrine Withdrawal Syndromes
The DOI matches its Crossref record; 174 of the 176 references it cites were found in a registry or an index.
Abstract
Hypersecretion of endogenous hormones or chronic administration of high doses of the same hormones induces varying degrees of tolerance and dependence. Elimination of hormone hypersecretion or discontinuation of hormone therapy may result in a mixed picture of two syndromes: a typical hormone deficiency syndrome and a generic withdrawal syndrome. Thus, hormones with completely different physiological effects may produce similar withdrawal syndromes, with symptoms and signs reminiscent of those observed with drugs of abuse, suggesting shared mechanisms. This review postulates a unified endocrine withdrawal syndrome, with changes in the hypothalamic-pituitary-adrenal axis and the central opioid peptide, in which noradrenergic and dopaminergic systems of the brain act as common links in its pathogenesis. Long-term adaptations to hormones may involve relatively persistent changes in molecular switches, including common intracellular signaling systems, from membrane receptors to transcription factors. The goals of therapy are to ease withdrawal symptoms and to expedite weaning of the patient from the hormonal excess state. Clinicians should resort to the fundamentals of tapering hormones down over time, even in the case of abrupt removal of a hormone-producing tumor. In addition, the prevention of stress and concurrent administration of antidepressants may ameliorate symptoms and signs of an endocrine withdrawal syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucocorticoid withdrawal syndrome occurs due to dependence on supraphysiologic glucocorticoids while decreasing the dose of glucocorticoids (70-72).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [70]
In the citing paper
“GWS likely occur due to physical dependence on supraphysiologic endogenous cortisol secretion prior to curative adrenalectomy.”
From Extensive clinical experience: hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess (2018) · cites this paper as [8]
Citations
Cites
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Subgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Self-citationDrug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,313
Cingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Effects of gonadal steroids in women with a history of postpartum depression
Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
Principles and Practice of Endocrinology and Metabolism.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-816_4 · Cited by 803
Research works printed but not linked: 1
- Lampit, 1998, Sleep activity in idiopatic short children: longer better sleep with growth hormone, Horm Res, 50, 120
Cited by
Items 101–178 of 178
ABUSE OF ANABOLIC ANDROGENIC STEROIDS
Yavari, A. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 11
Yuen, K. C. J., Moraitis, A. G., & Nguyen, D. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1097 · Cited by 11
Changes in Adrenal Function and Insufficiency Symptoms After Cessation of Prednisolone
Hansen, S. B., Dreyer, A. F., Jørgensen, N. T., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Borresen, S. W., Christensen, L. L., Glintborg, D., Hauge, E., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.1029 · Cited by 14
Faulhaber, M., Maeding, I., Malehsa, D., Raggi, M. C., Haverich, A., & Bara, C. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.02.012 · Cited by 10
Glicocorticóides e síndrome metabólica: aspectos favoráveis do exercício físico nesta patofisiologia
Pauli, J. R., Souza, L. S., Rogatto, G. P., Gomes, R., & Luciano, E. (2006) · Revista Portuguesa de Ciências do Desporto · doi:10.5628/rpcd.06.02.217 · Cited by 21
“…terapias locais, intervalos na utilização da droga, suplementação com cálcio, vitamina D3, admi-nistram-se hormônio do crescimento e estrogênio em humanos (3) e, recentemente, tem sido usado oligo-nucleotídeo antisense para o receptor de glicocorti-cóide (GR) em animais (7), entre outras.”
BackgroundTreatment of iatrogenic Cushing’s syndrome: questions of glucocorticoid withdrawal
Igaz, P., Rácz, K., Tóth, M., Gláz, E., & Tulassay, Z. (2007) · Orvosi Hetilap · doi:10.1556/oh.2007.27964 · Cited by 14
“Such mechanisms appear to participate in withdrawal syndromes developing after stopping the administration of other hormones (estrogenes/menopause, anabolic steroids) that may indicate the possibility of common pathways [28].”
BackgroundChallenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
Zhang, C. D., & Ioachimescu, A. G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1353543 · Cited by 12
Lampit, M., & Hochberg, Z. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8721 · Cited by 9
“Endocrine tolerance and withdrawal syndromes have been reported for several hormones ( 9 ).”
BackgroundSelf-citationGrowth Hormone Inhibitors in Prostate Cancer: A Systematic Analysis
Schmid, H., Gregorin, J., & Altwein, J. E. (2008) · Urologia Internationalis · doi:10.1159/000137635 · Cited by 9
“At this point, withdrawal of the anti-androgen may result in a short-term clinical response based on augmented receptor sensitivity to very low levels of testosterone.This endocrine withdrawal syndrome usually lasts not longer than 4–6 months and is accompanied by enhanced apoptosis and tumor shrinkage [”
BackgroundSandooja, R., Saini, J., Taveras, E. F., Garcia, R. G., Zhang, C. D., Fell, V. M., Peersen, A. F., Achenbach, S. J., Atkinson, E. J., Gompel, J. J. V., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf092 · Cited by 9
Murphy, S., Wang, L., Anderson, L. A., Steinlauf, A. F., Present, D. H., & Mechanick, J. I. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04136.x · Cited by 8
Síndrome de Cushing exógena e retirada de glicocorticóides
Romanholi, D. J. P. C., & Salgado, L. R. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800014 · Cited by 22
Postoperative Considerations Following Pituitary Surgery: A Guide for Clinicians
Giraldi, E. A., & Ioachimescu, A. G. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.06.018 · Cited by 9
Asadikaram, G., Akbari, H., Vakili, S., Asiabanha, M., Shahrokhi, N., & Savardashtaki, A. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.466 · Cited by 7
“The consumption of morphine and its derivatives can increase the level of corticosterone and progesterone (11,12).”
BackgroundGlucocorticoid Withdrawal Syndrome
Hochberg, Z. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000127931.93592.fb · Cited by 7
Self-citationPauli, J. R., Leme, J. A. C. D. A., Crespilho, D. M., de Mello, M. A. R., Rogatto, G. P., & Luciano, E. (2005) · Revista Portuguesa de Ciências do Desporto · doi:10.5628/rpcd.05.02.143 · Cited by 15
“O uso de glicocorticóides ocorre com freqüência na população, sendo uma das drogas mais prescritas e utilizadas em todo mundo, em várias condições clínicas (5, 14).”
BackgroundPrelle, K., Igl, B., Obendorf, M., Girbig, D., Lehmann, T., & Patchev, V. K. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318245533f · Cited by 5
Egalini, F., Caprino, M. P., Gaggero, G., Cappiello, V., Giannelli, J., Giaccherino, R. R., Pagano, L., & Giordano, R. (2021) · Endocrines · doi:10.3390/endocrines2030018 · Cited by 5
Laspro, M., Hoffman, A., Chinta, S. R., Abdalla, J., Tran, D. D., Oh, C., Robinson, I. S., & Rodriguez, E. D. (2024) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000010840 · Cited by 4
Hypertrophic Obstructive Cardiomyopathy in an Infant With an Adrenocortical Tumor
Hauser, J. A., Riedl, S., Michel‐Behnke, I., Minkov, M., Perneczky-Hintringer, E., & Horcher, E. (2013) · PEDIATRICS · doi:10.1542/peds.2012-2692 · Cited by 5
Huber, C. G., Fischer, M., Mohr, M., & Agorastos, A. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11030076 · Cited by 4
Do glucocorticoids induce addiction in humans?
Giordano, R., Guaraldi, F., Mazzoli, M., & Ghigo, E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0656-4 · Cited by 4
“withdrawal syndrome [8, 10], since acute stress-induced HPA activation and dopamine release in the mesolimbic system promote behavioral activation toward appropriate stimulus response, while prolonged stress exposure inhibits the mesolimbic dopaminergic system, with failure of coping, and subsequent depressive manifes…”
BackgroundResultInfluentialPezeshki, B., Pourmontaseri, H., Homayounfar, R., Moghaddam, M. T., & Dehghan, A. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01467-3 · Cited by 3
Over-the-counter Use of Glucocorticoids causing Severe Stunting in Siblings
Kumar, K., Sharma, R., Kumar, J., Kumar, P., Ramanan, P. V., Goyal, J. P., & Vijayasekaran, D. (2019) · Indian Pediatrics · doi:10.1007/s13312-019-1510-x · Cited by 3
Neurological Complications of Chemotherapy and Radiation Therapy
Grimm, S. A., & DeAngelis, L. M. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50031-6 · Cited by 3
Pope, S. E., Rooyen, C. V., Xu, A. J., Childers, H., Mishra, K., Tollinche, L. E., & Izquierdo, M. (2024) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2024.11.019 · Cited by 3
Mosquera, J. E., Rahimi, L., & Hamidi, O. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000920 · Cited by 3
Wang, W., Wang, J. N., Yu, W., Zhu, S. N., Gao, Y., & Zhang, J. Q. (2023) · PubMed Central · doi:10.19723/j.issn.1671-167x.2023.06.017 · Cited by 2
Modelo de intervención temprana en la depresión posparto en un hospital de tercer nivel
Lara, L. A., Ornelas, J. R., Rivera, W. A., Bocanegra, E. E. C., Madrigal, G. O., Díaz, M. C., Ambriz, S. G., & Chávez, J. F. C. (2012) · Revista de especialidades m�dico-quir�rgicas · Cited by 7
Ansari, S., sabzechian, M., Rouhani, F., Kiumarsi, A., & Rostami, T. (2014) · International Journal of Contemporary Pediatrics · doi:10.5455/2349-3291.ijcp20141115 · Cited by 2
Management of glucocorticoids following adrenalectomy for ACTH ‐independent Cushing's syndrome
Seejore, K., & Murray, R. D. (2018) · Clinical Endocrinology · doi:10.1111/cen.13839 · Cited by 2
de Oliveira, V. G., Justus, J. S., Portela, L. V., & Rodolphi, M. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_136 · Cited by 2
White, J., Ghomeshi, A., Deebel, N. A., Miller, D. T., Rahman, F., Venigalla, G., Sandler, M. D., Tomlinson, A. F., & Ramasamy, R. (2023) · Cureus · doi:10.7759/cureus.41134 · Cited by 4
“Previous studies have demonstrated that, after discontinuing AAS, patients have withdrawal symptoms, including transient flu-like symptoms, depression, decreased sex drive, fatigue, muscle pain, joint pain, headaches, and cravings to resume steroids [12-14].”
BackgroundTreatment of Iatrogenic Cushing’s Syndrome: Questions of Glucocorticoid Withdrawal
Igaz, P., Rácz, K., Tóth, M., Gláz, E., & Tulassay, Z. (2007) · Hungarian Medical Journal · doi:10.1556/oh-hmj.2007.27964 · Cited by 4
Shriyan, P., Sudhir, P. M., van Schayck, O. C. P., & Babu, G. R. (2024) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2024.100374 · Cited by 2
“15,16 Studies during pregnancy investigating the effects of the HPA on birth outcomes and maternal mental health status have shown mixed results.”
MethodResultInfluentialPauli, J. R. (2005) · Americanae (AECID Library) · Cited by 4
Peri-Transfer Glucocorticoid Therapy in Oocyte-Donation IVF Bridging the Immunological Gap
Voros, C., Chatzinikolaou, F. G., Papadimas, G. K., Polykalas, S., Mavrogianni, D., Koulakmanidis, A.-M., Athanasiou, D., Kanaka, V., Bananis, K., Athanasiou, A. I., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031217 · Cited by 1
“Treatment duration may vary from three days to three weeks, with dosages ranging from “physiological replace-ment” (5 mg prednisone per day) to somewhat pharmacological (20–30 mg per day) [72].”
Dreyer, A. F., Hansen, S. B., Borresen, S. W., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Christensen, L. L., Glintborg, D., Jensen, R. C., Jørgensen, N. T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111334 · Cited by 1
Síndrome de supresión de corticoides
Corral, B. P., Matilla, R. A., Martin, R. M. A.-S., Ballesteros-Pomar, M. D., Roiz, V., & Rodríguez, I. C. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71470-5 · Cited by 1
Corticoides tópicos e insuficiencia suprarrenal secundaria: una relación en la sombra
Pardo, R. M., Pelayo, M. P., Calvo, A. A., Rodríguez, S. G., & Barbeito, M. B. M. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.003 · Cited by 1
Chen, G., Lin, H., & Wu, C. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.04021.x · Cited by 1
Mirtazapine Is Effective in Steroid Withdrawal Syndrome Related Depression: A Case Report
Khanra, S., & Das, S. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.1.73 · Cited by 1
Perioperative management of VTE risk in patients on estrogen therapy
Tashjian, B., & Selzer, A. R. (2022) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2022.100284 · Cited by 1
Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities
Ben-Shlomo, A., Koh, M., Kremen, S. A., & Wertheimer, J. C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf029 · Cited by 4
Corticothérapie et fonction surrénale
Oliver, C. (2009) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(09)49740-0 · Cited by 1
Topical corticosteroids and secondary adrenal insufficiency: A relationship in the shade
Pardo, R. M., Pelayo, M. P., Calvo, A. A., Rodríguez, S. G., & Barbeito, M. B. M. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.11.001 · Cited by 1
Prophylaxe beim hereditären Angioödem (HAE) mit C1‐Inhibitormangel
Greve, J., Straßen, U., Gorczyza, M., Dominas, N., Frahm, U., Mühlberg, H., Wiednig, M., Zampeli, V., & Magerl, M. A. K. (2016) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12856_g · Cited by 1
Tratamiento del síndrome de cushing iatrogénico: cuestiones de abstinencia de glucocorticoides
Zambrano, N. A. B., Torres, A. I. R., Chiquito, H. M. C., & Choez, C. A. C. (2020) · RECIAMUC · doi:10.26820/reciamuc/4.(4).noviembre.2020.170-179 · Cited by 1
Brower, K. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_25
Corticoïdes : modalités d’arrêt du traitement
Coutant, R., Bouhours‐Nouet, N., Gatelais, F., & Dufresne, S. (2011) · Archives de Pédiatrie · doi:10.1016/s0929-693x(11)70973-3
Beyond Progesterone and Estrogen: Maternal Psychiatric Disturbances Linked to Adrenal Androgens
Marrs, C., Ferraro, D., & Cross, C. L. (2015) · doi:10.13140/rg.2.1.4952.4328
Diário de bordo - Ventos alísios
Bento, J. (2006) · Revista Portuguesa de Ciências do Desporto · doi:10.5628/rpcd.06.02.137
Glukokortikoidi v nefrologiji I: farmakologija in stranski učinki
Pajek, J., & Jensterle, M. (2015) · Slovenian Medical Journal · doi:10.6016/zdravvestn.1236 · Cited by 1
Fujii, K., Miyashita, K., Kurihara, I., Hiratsuka, K., Sato, S., Yokota, K., Kobayashi, S., Shibata, H., & Itoh, H. (2016) · Case Reports in Endocrinology · doi:10.1155/2016/2347528
“The mechanism of SWS is still unknown; however, it is assumed that long-term exposure to glucocorticoids causes the patients to develop a dependence on glucocorticoids [9].”
BackgroundRowe, T. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32122-3
[Cushing's syndrome. II. New forms of treatment].
van Aken, M. O., Feelders, R. A., van der Lely, A. J., Romijn, J. A., Lamberts, S. W. J., & de Herder, W. W. (2006) · PubMed · Cited by 4
Le recours aux androgènes est-il indiqué dans le cas des femmes?
Rowe, T. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32123-5
Posttreatment Management of Cushing’s Disease
Prete, A., & Salvatori, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804340-0.00009-7 · Cited by 1
Lefèbvre, H., & Goichot, B. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.009
Hypothalamic–Pituitary–Adrenal Suppression
Nicolaides, N. C., & Chrousos, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65817-8
Self-citationAdrenal Function and Skeletal Regulation
Chiodini, I., Battista, C., Cairoli, E., Eller-Vainicher, C., Morelli, V., Palmieri, S., Salcuni, A. S., & Scillitani, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-75110-8_7
Placenta Consumption and Probable Benefit-Damage Profile
Güdücü, N., & Özcan, N. K. (2018) · Archives of Health Science and Research · doi:10.17681/hsp.363853
Updates on hereditary angioedema in pediatrics
El-Ghoneimy, D. H. (2019) · The Egyptian Journal of Pediatric Allergy and Immunology · doi:10.21608/ejpa.2019.53988
“15 It is unclear if stopping long term prophylaxis with attenuated androgens should be done by tapering off gradually over time.(71)”
BackgroundMunir, M. A., Agarwal, S., & Zhang, J. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4836-7.00059-6
Piatkowski, T. M. (2020) · Queensland University of Technology · doi:10.5204/thesis.eprints.205442 · Cited by 1
Ampliacion de la Academia de Artes de Cranbrook
Vallés, J. R. M. (2000) · Croquis
Aulinas, A., & Webb, S. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-90475-3_7
Corticotropin-Dependent Cushing Syndrome Can Be Frequently Misdiagnosed
Young, W. F., & Bancos, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79285-1.00054-6
Young, W. F., & Bancos, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-79285-1.00016-9
Herbers, J. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-21521-6.00006-x
de Oliveira, V. G., Justus, J. S., Portela, L. V., & Rodolphi, M. S. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_136-1 · Cited by 1
Research Progress of HPA Axis and Perinatal Depressive Symptoms
李, 星. (2024) · Nursing Science · doi:10.12677/ns.2024.135077
Gender Transition: A Consideration for Anesthesia
Pajek, S., Verling, S. D., & Smaka, T. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-48503-9_11
Hypothalamic–pituitary–adrenal suppression
Kelsall, A., & Newell-Price, J. D. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00139-4
Psycho-Neurological and Immunological Aspects of Cushing’s Syndrome
Matos, T., Sapinho, I., Sagarribay, A., & Marques, P. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_28
Ectopic ACTH-dependent Cushing syndrome due to mature ovarian teratoma
Eisa, N. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-271716
Potential mechanisms of the glucocorticoid withdrawal syndrome
Snyder, C. N., Frontera, E. D., Meng, J., Wallace, B. I., & Spencer-Segal, J. L. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag062
Glucocorticoid-induced adrenal insufficiency from a supplement containing undisclosed dexamethasone
Fatima, H., Johal, L., Ibrahim, A., Ghotra, G. S., & Reddy, A. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag277
“In patients with chronic glucocorticoid exposure, withdrawal symptoms of myalgias, fatigue, weakness, nausea, and sleep disturbance can occur due to increased inflammatory cytokines after abrupt glucocorticoid cessation [5].”
Metadata
- Authors
- Hochberg, Z., Pacak, K., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Pediatric and Reproductive Endocrinology Branch (Z.H., K.P., G.P.C.), National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 523-538
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2033339602
- Cited by
- 181
- References
- 176
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 14 · 2023: 13 · 2022: 14 · 2021: 5 · 2020: 7 · 2019: 3 · 2018: 14 · 2017: 6 · 2016: 7 · 2015: 8 · 2014: 5 · 2013: 10 · 2012: 4
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- hormone dependence, hormone hypersecretion, hypothalamic-pituitary-adrenal axis, opioid peptides, noradrenergic system, dopaminergic system, hormone receptor signaling, transcription factors, hormone-producing tumors, antidepressants, stress prevention
- MeSH terms
- Androgens, Endocrine System, Estrogens, Female, Glucocorticoids, Hormones, Humans, Hypothalamo-Hypophyseal System, Male, Pituitary-Adrenal System, Substance Withdrawal Syndrome, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.